Skip to content

Cell Source, Inc.: 10-Q filed 2019-11-14

What Cell Source, Inc. reported in its quarterly report filed 2019-11-14 (fiscal Q3 2019): 21 published measures, 68 facts as tagged in accession 0001165527-19-000195.

This filing

Form
10-Q (quarterly report)
Filed
2019-11-14
Fiscal period
fiscal Q3 2019
Accession
0001165527-19-000195 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Cell Source, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-09-3077,447USD
At 2018-12-3165,792USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-09-305,991,995USD
At 2018-12-314,985,963USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-09-30-5,914,548USD
At 2019-06-30-5,153,771USD
At 2019-03-31-5,111,461USD
At 2019-01-01-4,920,171USD
At 2018-12-31-4,920,171USD
At 2018-09-30-6,069,254USD
At 2018-06-30-5,877,247USD
At 2018-03-31-5,327,054USD
At 2018-01-01-4,557,374USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-09-308,831USD
At 2018-12-3118,934USD
At 2018-09-308,121USD
At 2017-12-31371,048USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-1,487,966USD92
2019-01-01 to 2019-09-30-3,899,460USD273
2018-07-01 to 2018-09-30-404,825USD92
2018-01-01 to 2018-09-30-1,557,738USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-09-30-1,723,872USD273
2018-01-01 to 2018-09-30-1,412,927USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-09-301,713,769USD273
2018-01-01 to 2018-09-301,050,000USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-09-30-20,569,793USD
At 2018-12-31-16,670,333USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-1,436,699USD92
2019-01-01 to 2019-09-30-3,337,639USD273
2018-07-01 to 2018-09-30-488,646USD92
2018-01-01 to 2018-09-30-1,572,665USD273

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-26,418USD92
2019-01-01 to 2019-09-30-159,202USD273
2018-07-01 to 2018-09-30-30,923USD92
2018-01-01 to 2018-09-30-124,774USD273

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-09-30448,523USD
At 2018-12-31277,786USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-07-01 to 2019-09-301,436,699USD92
2019-01-01 to 2019-09-303,337,639USD273
2018-07-01 to 2018-09-30488,646USD92
2018-01-01 to 2018-09-301,572,665USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2019-07-01 to 2019-09-30244,609USD92
2019-01-01 to 2019-09-30985,037USD273
2018-07-01 to 2018-09-30359,660USD92
2018-01-01 to 2018-09-301,031,517USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-07-01 to 2019-09-301,158,757USD92
2019-01-01 to 2019-09-302,269,269USD273
2018-07-01 to 2018-09-3056,459USD92
2018-01-01 to 2018-09-30165,997USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-09-3026,479,471shares
At 2018-12-3126,077,611shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-09-3014,627,597USD
At 2018-12-3111,723,224USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-09-301,121,881USD
At 2018-12-31532,790USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-1,487,966USD92
2019-04-01 to 2019-06-30-952,985USD91
2019-01-02 to 2019-03-31-1,458,509USD89
2018-07-01 to 2018-09-30-404,825USD92
2018-04-01 to 2018-06-30-440,729USD91
2018-01-02 to 2018-03-31-712,184USD89

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-1,685,877USD92
2019-01-01 to 2019-09-30-4,434,379USD273
2018-07-01 to 2018-09-30-515,491USD92
2018-01-01 to 2018-09-30-1,885,364USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2018-01-01 to 2018-09-3018,030USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-01-01 to 2019-09-30170,737USD273
2018-01-01 to 2018-09-3087,208USD273

Inspect the source

Entity
Cell Source, Inc. / CIK 0001569340
Captured
2026-09-20T09:20:59.488Z
SEC response SHA-256
a38ee9440e4c17d7e1a60b5c62fea787c32a17056a875641a758e857a5dd95d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001569340.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))